Archive for the ‘IPS Cell Therapy’ Category
National Medical Report
Fate Therapeutics: Founded in 2007 on the leading stem cell and developmental biology research, Fate Therapeutics is using the fundamental biological mechanisms that guide cell fate to develop small molecule and biologic therapeutics for diseases and conditions that currently have limited to no treatment options.
Read the original post:
National Medical Report
National Medical Report
Fate Therapeutics: Founded in 2007 on the leading stem cell and developmental biology research, Fate Therapeutics is using the fundamental biological mechanisms that guide cell fate to develop small molecule and biologic therapeutics for diseases and conditions that currently have limited to no treatment options.
See more here:
National Medical Report
IPs Cells Part 4
Dr.George Daley of Boston Children's Hospital explains the concept of Induced Pluripotent Stem Cells.
Continue reading here:
IPs Cells Part 4
Jeanne Loring talks about stem cells, part 2
Jeanne Loring talks about stem cells, part 2. Part of meeting between Parkinson's patients and researchers in Loring's lab about the potential of induced pluripotent stem cell therapy, Aug. 4, 2011
Read the original post:
Jeanne Loring talks about stem cells, part 2
Myelin Repair Foundation on Stem Cell Research
President Obama's lifting of federal restrictions on the use of embryonic stem cells in scientific research has generated considerable news coverage and many questions from our supporters about the impact of this reversal on our own research.
Here is the original post:
Myelin Repair Foundation on Stem Cell Research
A Century of Stem Cells – Johns Hopkins Medicine
A brief overview of the milestones in stem cell research over that past 100 years.
Read this article:
A Century of Stem Cells - Johns Hopkins Medicine
Stem Cell Implications for ALS (Amyotrophic Lateral Sclerosis)
At Johns Hopkins, researchers and doctors are working together to explore the impact of stem technology on ALS. The Robert Packard Center for ALS Research at Johns Hopkins has helped uncover new genes for familial ALS, researched nerve repair, worked actively on genetic risk factors, developed a variety of animal models for testing therapies, explored ALS biology, advanced stem cell therapy, and researched ways to counter muscle atrophy.
Read the original post:
Stem Cell Implications for ALS (Amyotrophic Lateral Sclerosis)
IPs cells Part 1
Dr. George Daley of Boston Children's Hospital explains the concept of Induced Pluripotent Stem Cells.
Continue reading here:
IPs cells Part 1
Ying Liu discusses IPS cell therapy for ALS
Ying Liu, a Scripps Clinic researcher in the lab of stem cell scientist Jeanne Loring, discusses the biological underpinnings of the technology for using induced pluripotent stem cells for treated ALS, or Lou Gehrig's disease.
Here is the original post:
Ying Liu discusses IPS cell therapy for ALS